-
Mashup Score: 0
Patients on certain DMTs seem to fare worse and careful timing of vaccination is advisable.
Source: www.mdedge.comCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
Presenting at CMSC 2022, researchers analyzed the development of whole-brain atrophy and white matter lesions in patients with CDMS.
Source: Neurology AdvisorCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
In a quantitative study, researchers assessed the efficacy of TMS on depressive symptoms in people with MS.
Source: Neurology AdvisorCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
Presenting at CMSC 2022, researchers obtained real-world data on the efficacy and safety of oral cladribine in patients with relapsing-remitting multiple sclerosis.
Source: Neurology AdvisorCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
Presenting at CMSC 2022, researchers evaluated whether racial patterns exist in NMOSD- and MOGAD-associated ON and the potential role of social disadvantage in these patterns.
Source: Neurology AdvisorCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
Presenting at CMSC 2022, researchers evaluated COVID-19 outcomes among patients with MS who received treatment with ofatumumab.
Source: Neurology AdvisorCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
Presenting at CMSC 2022, researchers observed how ECG patterns relate to different demographic, clinical, and patient-specific characteristics in patients with MS.
Source: Neurology AdvisorCategories: Latest Headlines, NeurologyTweet
While patients with MS aren’t more likely to be infected with COVID, it’s not clear whether they face a higher mortality risk, especially if taking certain DMTs. https://t.co/DWvFf8BVtn #CMSC2022 https://t.co/j5kDr5fUtw